BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21306352)

  • 1. Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.
    Rizopoulos D
    Biometrics; 2011 Sep; 67(3):819-29. PubMed ID: 21306352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective accuracy for longitudinal markers.
    Zheng Y; Heagerty PJ
    Biometrics; 2007 Jun; 63(2):332-41. PubMed ID: 17688486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible B-spline model for multiple longitudinal biomarkers and survival.
    Brown ER; Ibrahim JG; DeGruttola V
    Biometrics; 2005 Mar; 61(1):64-73. PubMed ID: 15737079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes.
    Rizopoulos D; Verbeke G; Molenberghs G
    Biometrics; 2010 Mar; 66(1):20-9. PubMed ID: 19459832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-part joint model for the analysis of survival and longitudinal binary data with excess zeros.
    Rizopoulos D; Verbeke G; Lesaffre E; Vanrenterghem Y
    Biometrics; 2008 Jun; 64(2):611-9. PubMed ID: 17725808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jointly Modeling Event Time and Skewed-Longitudinal Data with Missing Response and Mismeasured Covariate for AIDS Studies.
    Huang Y; Yan C; Xing D; Zhang N; Chen H
    J Biopharm Stat; 2015; 25(4):670-94. PubMed ID: 24905593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric approaches for joint modeling of longitudinal and survival data with time-varying coefficients.
    Song X; Wang CY
    Biometrics; 2008 Jun; 64(2):557-66. PubMed ID: 17725812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data.
    Wu L; Hu XJ; Wu H
    Biostatistics; 2008 Apr; 9(2):308-20. PubMed ID: 17728318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
    J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
    Huang Y; Dagne G; Wu L
    Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian mixture of semiparametric mixed-effects joint models for skewed-longitudinal and time-to-event data.
    Chen J; Huang Y
    Stat Med; 2015 Sep; 34(20):2820-43. PubMed ID: 25924891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling progression of CD4-lymphocyte count and its relationship to survival time.
    De Gruttola V; Tu XM
    Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
    Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.
    Thiébaut R; Jacqmin-Gadda H; Leport C; Katlama C; Costagliola D; Le Moing V; Morlat P; Chêne G;
    J Biopharm Stat; 2003 May; 13(2):271-82. PubMed ID: 12729394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial multistate transitional models for longitudinal event data.
    Nathoo FS; Dean CB
    Biometrics; 2008 Mar; 64(1):271-9. PubMed ID: 17425639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia.
    Deslandes E; Chevret S
    Stat Med; 2007 Dec; 26(30):5411-21. PubMed ID: 18058850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint models for efficient estimation in proportional hazards regression models.
    Slasor P; Laird N
    Stat Med; 2003 Jul; 22(13):2137-48. PubMed ID: 12820279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.